id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-1021-0089,FDA,FDA-2012-N-1021,Instructions for Submitting Comments on the CDRH Fiscal Year 2024 Proposed Guidance Development,Other,Additional Information,2023-11-13T05:00:00Z,2023,11,2023-11-13T05:00:00Z,2023-12-12T04:59:59Z,2024-01-18T02:00:39Z,,0,0,090000648625b907